Showing results (11-20 of 233) with videos related to
Sort By:
Pageof 24
Expert Review of Hematology|August 12, 2014
Siltuximab for multicentric Castleman diseaseYi-Chang Liu, Katie Stone, Frits van RheeTherapeutic Advances in Hematology|March 7, 2022
Idiopathic multicentric Castleman disease treated with siltuximab for 15 years: a case reportEvan Lang, Brenda Sande, Samantha Brodkin, et al.Transplant Infectious Disease : an Official Journal of the Transplantation Society|April 20, 2021
Ehrlichia-induced hemophagocytic lymphohistiocytosis after autologous stem cell transplantAngel A Mitma, Mary J Burgess, Frits van RheeLeukemia & Lymphoma|June 14, 2003
Predicting long-term survival in multiple myeloma patients following autotransplantsAthanasios B T Fassas, Frits Van Rhee, Guido TricotCurrent Oncology Reports|February 12, 2025
Current State of Evidence on Definitions and Management of High-Risk Multiple MyelomaBhavesh Mohan Lal, Frits van Rhee, Samer Al HadidiExpert Opinion on Biological Therapy|July 9, 2026
Treating Castleman disease: insights into the use and efficacy of monoclonal antibodiesYoshito Nishimura, Thomas Habermann, Angela Dispenzieri, et al.Ejhaem|May 19, 2023
Acquired hemophilia A (AHA) due to anti-SARS-CoV-2 vaccination: A systematic reviewFnu Amisha, Prachi Saluja, Paras Malik, et al.Blood|March 14, 2014
HHV-8-negative, idiopathic multicentric Castleman disease: novel insights into biology, pathogenesis, and therapyDavid C Fajgenbaum, Frits van Rhee, Christopher S NabelClinical Lymphoma, Myeloma & Leukemia|January 19, 2016
Atrial Fibrillation in Hematologic Malignancies, Especially After Autologous Hematopoietic Stem Cell Transplantation: Review of Risk Factors, Current Management, and Future DirectionsPankaj Mathur, Hakan Paydak, Sharmilan Thanendrarajan, et al.Pageof 24